Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 611–620 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 611
- Medicine slug
- filgrastim-txid
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
3.5 hours
- Numeric value
- 3.5
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:89092bb8-6a20-e23e-e053-2a95a90aa750 (opens source in a new tab)
Filgrastim-Txid label
Version not recorded · Effective date not recorded
After intravenous administration, the volume of distribution averaged 150 mL/kg and the elimination half-life was approximately 3.5 hours in both normal subjects and subjects with cancer.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:575d164d-45fa-4e3e-81e4-2652d96673d1 (opens source in a new tab)
Filgrastim-Txid label
Version not recorded · Effective date not recorded
After intravenous administration, the volume of distribution averaged 150 mL/kg and the elimination half-life was approximately 3.5 hours in both normal subjects and subjects with cancer.
Projected row 612
- Medicine slug
- finasteride
- Compared field
- bioavailability
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 75
- Source count
- 75
- Agreement rate
- 0.666667
- Recorded readings
63%
- Numeric value
- 63
- Unit
- %
- Source records
- 50
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 50 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdde1382-a995-4f53-9497-7724d5e25b66 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c1bf77c-f99a-44e4-b71e-ce766afa99b6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:33295dce-1e81-4187-bce1-d9b332ea062e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61e6cbb8-ddd2-4e07-b182-6348f216858b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22161236-6804-4a7f-86cb-cfa20bd1951e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7806f5d3-504a-4b6e-b566-22181f076d3f (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32266029-c710-44dd-943f-7e31d0afa622 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cb6a9f1-f7a6-46be-9b2b-8f228c821b4d (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6ee2f07-63a6-4fde-88de-654bf633529e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe7e6ea7-583e-22d4-e053-6394a90a2526 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9a3cb34-9a8e-4538-ab90-32e08d8acc3a (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:845cad9c-c50d-4c98-8df8-893d1241836a (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5efc695c-d9fd-4892-a63f-a35cceb8d3c7 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c3b1f6b-0010-4432-8eda-4af3c3573063 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:800fa54c-c008-ba1e-e053-2a91aa0a2b07 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3272651f-b500-4d5d-9e29-22fcd8e24fcb (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:57e73fff-2115-41ad-864b-4652f9fd4545 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:adfb8f6b-a7bb-4ac2-b2aa-fec6d56630ad (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f988153-fc74-4ca4-b29a-111f750c4a4b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34-108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e482a50d-db15-4407-85c9-160c88e8a657 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc9709ce-2d29-48bd-b46b-3f72114f2527 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f468081-254a-4f11-9f0b-c0311e353a50 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bafe8674-b7ee-47b2-94c1-842164ca6fa1 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6360d8cc-72df-c571-e053-2991aa0a72c5 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9ae38bf5-17d7-4af1-922f-b3edb1e65392 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5087f6f2-92c0-3feb-e063-6394a90ab17d (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa3fcd1a-02a1-49db-b40e-75e623d730e1 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9ea2f77-11c3-4dbf-bdc4-d1b0e7437990 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e69ea84-dc5a-4aac-9353-4920c6f7b3aa (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88511bd5-624e-49d6-b80e-1f1d47314fb6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc9c4996-302c-2ad8-e053-6294a90a5f38 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29e59387-120c-4367-9f87-75cb53b6460d (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13673a09-8a50-5cd0-e063-6294a90a3d5b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
to close to baseline value after approximately three months of discontinuation of therapy. 12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2875bc7-e811-4860-9131-da06cecc2137 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3fec2bcb-91b8-4041-9ee8-e5a4ebe5fd04 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da4e8a51-cf1c-4018-976f-edecc4934a39 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7a3af01-de3f-4cd4-ba05-a41ca0544ac2 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:549aab5d-819a-1691-e054-00144ff88e88 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e31a5901-ef04-4515-bca4-79118a3f3797 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ef9c0b23-4736-4fb0-862c-c2a4d644e0d6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d726486-f9ef-49d1-b1ae-6b1c8650fa73 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a3b49681-09b3-4c26-bb57-3dfd598d48b6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b38c8c7-01e4-45d0-b4ee-3546d9ad849c (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:350b2bdb-84a1-4465-b0ad-175b8f720400 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d66fe4bd-534b-4674-a346-0cf3cdabbfaa (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4dd6d6c-c8c7-16a9-aa68-aa46283dfae1 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54c73290-bdc1-3453-e054-00144ff88e88 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8ed59a3-c5b2-3156-b781-5e514b79011b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c688ec5-1b0f-2269-e063-6394a90a7220 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5 mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:77589cc3-c440-4695-800c-82a0e5128a6c (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study of 15 healthy young subjects, the mean bioavailability of finasteride 5-mg tablets was 63% (range 34 to 108%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
65%
- Numeric value
- 65
- Unit
- %
- Source records
- 25
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 25 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f904709-65aa-44ce-b144-b4c8a0416e36 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26-170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e3728709-e805-4b46-9954-2c433a865987 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b84a67d6-695e-4a7c-9b60-95e9ad18a501 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2cac9e5-ea52-44b7-ae88-78e11a732904 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1 mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3fe7bdaa-b027-4da9-94ee-550bf28c63e1 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ecd2fbb2-a4bd-44f2-831d-179e7dbf0741 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90cc0d22-fa5c-4fe4-b0bf-554b715a05ac (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b63af2cd-5c12-4977-bac4-95e1eae11e57 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8488cd17-365c-701c-e053-2991aa0af5f9 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1 mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49eb3a1e-d7e6-4652-aa6d-6abf21af34a6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03429cec-c6b5-47fe-bb11-6b42f977df7e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1 mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abd87058-923f-4767-986c-278201c0e688 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1 mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01b88593-99d3-4dd6-a7b6-5438c15bd7b7 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1 mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74b90430-8ce1-470c-939c-685ca9dfd74f (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1 mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:870ab7fe-fff9-4348-b900-213c1cf05f8e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7d140366-2388-488e-bd86-67e6edf44345 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1 mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8516eaa-98d0-4eb1-bc65-aa765baea5db (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1 mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:196f7d23-ed90-46c2-ae34-615e6ec1650b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9acbe693-8448-b443-9f78-1f9972520798 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:291a2037-2b4f-a2fe-e063-6294a90a1e9a (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e955ce4-d44e-4b4d-b763-ab141cb3f06d (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51286a03-c29c-2c0b-e063-6394a90af33c (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1 mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f2626ef-66d9-6a77-e053-2995a90af056 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa19372d-027d-a91b-f58e-1bdb8fd7e2b6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1 mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00e934bb-c15b-490a-a852-839689a1231a (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption In a study in 15 healthy young male subjects, the mean bioavailability of finasteride 1-mg tablets was 65% (range 26 to 170%), based on the ratio of area under the curve (AUC) relative to an intravenous (IV) reference dose.
Projected row 613
- Medicine slug
- finasteride
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 75
- Source count
- 75
- Agreement rate
- 0.666667
- Recorded readings
6 hours
- Numeric value
- 6
- Unit
- hours
- Source records
- 50
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 50 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdde1382-a995-4f53-9497-7724d5e25b66 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to ‑279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c1bf77c-f99a-44e4-b71e-ce766afa99b6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:33295dce-1e81-4187-bce1-d9b332ea062e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61e6cbb8-ddd2-4e07-b182-6348f216858b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22161236-6804-4a7f-86cb-cfa20bd1951e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7806f5d3-504a-4b6e-b566-22181f076d3f (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32266029-c710-44dd-943f-7e31d0afa622 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cb6a9f1-f7a6-46be-9b2b-8f228c821b4d (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6ee2f07-63a6-4fde-88de-654bf633529e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe7e6ea7-583e-22d4-e053-6394a90a2526 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9a3cb34-9a8e-4538-ab90-32e08d8acc3a (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:845cad9c-c50d-4c98-8df8-893d1241836a (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5efc695c-d9fd-4892-a63f-a35cceb8d3c7 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c3b1f6b-0010-4432-8eda-4af3c3573063 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:800fa54c-c008-ba1e-e053-2a91aa0a2b07 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3272651f-b500-4d5d-9e29-22fcd8e24fcb (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:57e73fff-2115-41ad-864b-4652f9fd4545 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:adfb8f6b-a7bb-4ac2-b2aa-fec6d56630ad (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f988153-fc74-4ca4-b29a-111f750c4a4b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70-279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3-16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e482a50d-db15-4407-85c9-160c88e8a657 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc9709ce-2d29-48bd-b46b-3f72114f2527 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f468081-254a-4f11-9f0b-c0311e353a50 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bafe8674-b7ee-47b2-94c1-842164ca6fa1 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6360d8cc-72df-c571-e053-2991aa0a72c5 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9ae38bf5-17d7-4af1-922f-b3edb1e65392 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5087f6f2-92c0-3feb-e063-6394a90ab17d (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa3fcd1a-02a1-49db-b40e-75e623d730e1 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9ea2f77-11c3-4dbf-bdc4-d1b0e7437990 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e69ea84-dc5a-4aac-9353-4920c6f7b3aa (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88511bd5-624e-49d6-b80e-1f1d47314fb6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc9c4996-302c-2ad8-e053-6294a90a5f38 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29e59387-120c-4367-9f87-75cb53b6460d (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13673a09-8a50-5cd0-e063-6294a90a3d5b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2875bc7-e811-4860-9131-da06cecc2137 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3fec2bcb-91b8-4041-9ee8-e5a4ebe5fd04 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da4e8a51-cf1c-4018-976f-edecc4934a39 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7a3af01-de3f-4cd4-ba05-a41ca0544ac2 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:549aab5d-819a-1691-e054-00144ff88e88 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e31a5901-ef04-4515-bca4-79118a3f3797 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ef9c0b23-4736-4fb0-862c-c2a4d644e0d6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d726486-f9ef-49d1-b1ae-6b1c8650fa73 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a3b49681-09b3-4c26-bb57-3dfd598d48b6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b38c8c7-01e4-45d0-b4ee-3546d9ad849c (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:350b2bdb-84a1-4465-b0ad-175b8f720400 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d66fe4bd-534b-4674-a346-0cf3cdabbfaa (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4dd6d6c-c8c7-16a9-aa68-aa46283dfae1 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54c73290-bdc1-3453-e054-00144ff88e88 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8ed59a3-c5b2-3156-b781-5e514b79011b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c688ec5-1b0f-2269-e063-6394a90a7220 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:77589cc3-c440-4695-800c-82a0e5128a6c (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Excretion In healthy young subjects (n=15), mean plasma clearance of finasteride was 165 mL/min (range, 70 mL/min to 279 mL/min) and mean elimination half-life in plasma was 6 hours (range, 3 to 16 hours).
4.5 hours
- Numeric value
- 4.5
- Unit
- hours
- Source records
- 25
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 25 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f904709-65aa-44ce-b144-b4c8a0416e36 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3-13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e3728709-e805-4b46-9954-2c433a865987 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b84a67d6-695e-4a7c-9b60-95e9ad18a501 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2cac9e5-ea52-44b7-ae88-78e11a732904 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3fe7bdaa-b027-4da9-94ee-550bf28c63e1 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 14 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ecd2fbb2-a4bd-44f2-831d-179e7dbf0741 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90cc0d22-fa5c-4fe4-b0bf-554b715a05ac (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b63af2cd-5c12-4977-bac4-95e1eae11e57 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8488cd17-365c-701c-e053-2991aa0af5f9 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49eb3a1e-d7e6-4652-aa6d-6abf21af34a6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03429cec-c6b5-47fe-bb11-6b42f977df7e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abd87058-923f-4767-986c-278201c0e688 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01b88593-99d3-4dd6-a7b6-5438c15bd7b7 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74b90430-8ce1-470c-939c-685ca9dfd74f (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:870ab7fe-fff9-4348-b900-213c1cf05f8e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7d140366-2388-488e-bd86-67e6edf44345 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8516eaa-98d0-4eb1-bc65-aa765baea5db (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:196f7d23-ed90-46c2-ae34-615e6ec1650b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9acbe693-8448-b443-9f78-1f9972520798 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:291a2037-2b4f-a2fe-e063-6294a90a1e9a (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e955ce4-d44e-4b4d-b763-ab141cb3f06d (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51286a03-c29c-2c0b-e063-6394a90af33c (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f2626ef-66d9-6a77-e053-2995a90af056 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa19372d-027d-a91b-f58e-1bdb8fd7e2b6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00e934bb-c15b-490a-a852-839689a1231a (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Mean terminal half-life in plasma was 4.5 hours (range, 3.3 to 13.4 hours; n=12).
Projected row 614
- Medicine slug
- finasteride
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 75
- Source count
- 75
- Agreement rate
- 1
- Recorded readings
76 liters
- Numeric value
- 76
- Unit
- L
- Source records
- 75
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 75 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdde1382-a995-4f53-9497-7724d5e25b66 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c1bf77c-f99a-44e4-b71e-ce766afa99b6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:33295dce-1e81-4187-bce1-d9b332ea062e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f904709-65aa-44ce-b144-b4c8a0416e36 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44-96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e3728709-e805-4b46-9954-2c433a865987 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61e6cbb8-ddd2-4e07-b182-6348f216858b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22161236-6804-4a7f-86cb-cfa20bd1951e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7806f5d3-504a-4b6e-b566-22181f076d3f (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32266029-c710-44dd-943f-7e31d0afa622 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b84a67d6-695e-4a7c-9b60-95e9ad18a501 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2cac9e5-ea52-44b7-ae88-78e11a732904 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cb6a9f1-f7a6-46be-9b2b-8f228c821b4d (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3fe7bdaa-b027-4da9-94ee-550bf28c63e1 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6ee2f07-63a6-4fde-88de-654bf633529e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe7e6ea7-583e-22d4-e053-6394a90a2526 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ecd2fbb2-a4bd-44f2-831d-179e7dbf0741 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9a3cb34-9a8e-4538-ab90-32e08d8acc3a (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90cc0d22-fa5c-4fe4-b0bf-554b715a05ac (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b63af2cd-5c12-4977-bac4-95e1eae11e57 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:845cad9c-c50d-4c98-8df8-893d1241836a (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5efc695c-d9fd-4892-a63f-a35cceb8d3c7 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8488cd17-365c-701c-e053-2991aa0af5f9 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c3b1f6b-0010-4432-8eda-4af3c3573063 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:800fa54c-c008-ba1e-e053-2a91aa0a2b07 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49eb3a1e-d7e6-4652-aa6d-6abf21af34a6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03429cec-c6b5-47fe-bb11-6b42f977df7e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3272651f-b500-4d5d-9e29-22fcd8e24fcb (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:57e73fff-2115-41ad-864b-4652f9fd4545 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abd87058-923f-4767-986c-278201c0e688 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01b88593-99d3-4dd6-a7b6-5438c15bd7b7 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:adfb8f6b-a7bb-4ac2-b2aa-fec6d56630ad (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f988153-fc74-4ca4-b29a-111f750c4a4b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44-96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e482a50d-db15-4407-85c9-160c88e8a657 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc9709ce-2d29-48bd-b46b-3f72114f2527 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f468081-254a-4f11-9f0b-c0311e353a50 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74b90430-8ce1-470c-939c-685ca9dfd74f (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bafe8674-b7ee-47b2-94c1-842164ca6fa1 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6360d8cc-72df-c571-e053-2991aa0a72c5 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9ae38bf5-17d7-4af1-922f-b3edb1e65392 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5087f6f2-92c0-3feb-e063-6394a90ab17d (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa3fcd1a-02a1-49db-b40e-75e623d730e1 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9ea2f77-11c3-4dbf-bdc4-d1b0e7437990 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e69ea84-dc5a-4aac-9353-4920c6f7b3aa (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:870ab7fe-fff9-4348-b900-213c1cf05f8e (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7d140366-2388-488e-bd86-67e6edf44345 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88511bd5-624e-49d6-b80e-1f1d47314fb6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8516eaa-98d0-4eb1-bc65-aa765baea5db (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:196f7d23-ed90-46c2-ae34-615e6ec1650b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9acbe693-8448-b443-9f78-1f9972520798 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:291a2037-2b4f-a2fe-e063-6294a90a1e9a (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc9c4996-302c-2ad8-e053-6294a90a5f38 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29e59387-120c-4367-9f87-75cb53b6460d (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13673a09-8a50-5cd0-e063-6294a90a3d5b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2875bc7-e811-4860-9131-da06cecc2137 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3fec2bcb-91b8-4041-9ee8-e5a4ebe5fd04 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da4e8a51-cf1c-4018-976f-edecc4934a39 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7a3af01-de3f-4cd4-ba05-a41ca0544ac2 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:549aab5d-819a-1691-e054-00144ff88e88 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e31a5901-ef04-4515-bca4-79118a3f3797 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e955ce4-d44e-4b4d-b763-ab141cb3f06d (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ef9c0b23-4736-4fb0-862c-c2a4d644e0d6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d726486-f9ef-49d1-b1ae-6b1c8650fa73 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a3b49681-09b3-4c26-bb57-3dfd598d48b6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51286a03-c29c-2c0b-e063-6394a90af33c (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b38c8c7-01e4-45d0-b4ee-3546d9ad849c (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:350b2bdb-84a1-4465-b0ad-175b8f720400 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d66fe4bd-534b-4674-a346-0cf3cdabbfaa (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4dd6d6c-c8c7-16a9-aa68-aa46283dfae1 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54c73290-bdc1-3453-e054-00144ff88e88 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f2626ef-66d9-6a77-e053-2995a90af056 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8ed59a3-c5b2-3156-b781-5e514b79011b (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa19372d-027d-a91b-f58e-1bdb8fd7e2b6 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c688ec5-1b0f-2269-e063-6394a90a7220 (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00e934bb-c15b-490a-a852-839689a1231a (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters; n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:77589cc3-c440-4695-800c-82a0e5128a6c (opens source in a new tab)
Finasteride label
Version not recorded · Effective date not recorded
Distribution Mean steady-state volume of distribution was 76 liters (range, 44 to 96 liters).
Projected row 615
- Medicine slug
- fingolimod
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 21
- Source count
- 21
- Agreement rate
- 1
- Recorded readings
93%
- Numeric value
- 93
- Unit
- %
- Source records
- 21
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 21 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1171df44-48b4-6ef2-e063-6294a90aa121 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5434bd4a-2610-0e17-4f14-513ff1cbb822 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd981e18-1766-4a2d-9a9b-965ec960aa06 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5402dd1-c496-405d-9cae-07ccf184339c (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6301307-55c6-4b91-a505-ff93c865f859 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc9e1c8c-0e2b-44e2-878b-27057f786be9 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b228dac8-b07d-424d-b23b-a03573517c54 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e738dbd9-f4cc-49a0-98ce-73dd0c3ff3b3 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a545c6fc-7006-52c2-f476-34e9801ac04f (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56badc2a-6747-9284-300e-bf072eb072ed (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9aa1078-fd72-47ef-84b2-2e1ad17b12a2 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54bf842e-9772-424d-87b2-61863b6f4b19 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65e59a51-c9c2-47b4-84fc-e0f8879eb26c (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8fe14efd-8f61-40db-9069-bb17daf3261a (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99e7daf4-ea90-5e47-e053-2a95a90ac1b7 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:550a5fa3-94a4-0b55-9cb5-c0178acfe319 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1960f9b-f739-452c-b167-245551bf3690 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0538769-3cec-4cf2-97e5-41e79599c181 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f638feb-6986-41e4-8f9c-2e6b84a5bb44 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c0faf2b-21fb-4830-bb78-5f2dbceb2c82 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c3199508-3d6a-4e44-96f0-bbde9969edcb (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
The apparent absolute oral bioavailability is 93%.
Projected row 616
- Medicine slug
- fingolimod
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 21
- Source count
- 21
- Agreement rate
- 1
- Recorded readings
6 to 9 days
- Numeric value
- Not parsed
- Unit
- Not recorded
- Source records
- 21
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 21 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1171df44-48b4-6ef2-e063-6294a90aa121 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3 ± 2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5434bd4a-2610-0e17-4f14-513ff1cbb822 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3 ± 2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd981e18-1766-4a2d-9a9b-965ec960aa06 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3 ± 2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5402dd1-c496-405d-9cae-07ccf184339c (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3 ± 2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6301307-55c6-4b91-a505-ff93c865f859 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3 ± 2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc9e1c8c-0e2b-44e2-878b-27057f786be9 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3 ± 2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b228dac8-b07d-424d-b23b-a03573517c54 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3±2.3 L/h, and the average apparent terminal half-life (t1/2) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e738dbd9-f4cc-49a0-98ce-73dd0c3ff3b3 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3±2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a545c6fc-7006-52c2-f476-34e9801ac04f (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3 ± 2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56badc2a-6747-9284-300e-bf072eb072ed (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3±2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9aa1078-fd72-47ef-84b2-2e1ad17b12a2 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3 ± 2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54bf842e-9772-424d-87b2-61863b6f4b19 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3±2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65e59a51-c9c2-47b4-84fc-e0f8879eb26c (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3±2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8fe14efd-8f61-40db-9069-bb17daf3261a (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3±2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99e7daf4-ea90-5e47-e053-2a95a90ac1b7 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3 ± 2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:550a5fa3-94a4-0b55-9cb5-c0178acfe319 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3 ± 2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1960f9b-f739-452c-b167-245551bf3690 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3±2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0538769-3cec-4cf2-97e5-41e79599c181 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3±2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f638feb-6986-41e4-8f9c-2e6b84a5bb44 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3±2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c0faf2b-21fb-4830-bb78-5f2dbceb2c82 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3 ± 2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c3199508-3d6a-4e44-96f0-bbde9969edcb (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Elimination Fingolimod blood clearance is 6.3 ± 2.3 L/h, and the average apparent terminal half-life (t 1/2 ) is 6 to 9 days.
Projected row 617
- Medicine slug
- fingolimod
- Compared field
- tMax
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 21
- Source count
- 21
- Agreement rate
- 0.952381
- Recorded readings
12 to 16 hours
- Numeric value
- 12
- Unit
- hours
- Source records
- 20
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 20 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1171df44-48b4-6ef2-e063-6294a90aa121 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5434bd4a-2610-0e17-4f14-513ff1cbb822 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd981e18-1766-4a2d-9a9b-965ec960aa06 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5402dd1-c496-405d-9cae-07ccf184339c (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6301307-55c6-4b91-a505-ff93c865f859 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc9e1c8c-0e2b-44e2-878b-27057f786be9 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b228dac8-b07d-424d-b23b-a03573517c54 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a545c6fc-7006-52c2-f476-34e9801ac04f (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56badc2a-6747-9284-300e-bf072eb072ed (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9aa1078-fd72-47ef-84b2-2e1ad17b12a2 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54bf842e-9772-424d-87b2-61863b6f4b19 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65e59a51-c9c2-47b4-84fc-e0f8879eb26c (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8fe14efd-8f61-40db-9069-bb17daf3261a (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99e7daf4-ea90-5e47-e053-2a95a90ac1b7 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:550a5fa3-94a4-0b55-9cb5-c0178acfe319 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1960f9b-f739-452c-b167-245551bf3690 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0538769-3cec-4cf2-97e5-41e79599c181 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f638feb-6986-41e4-8f9c-2e6b84a5bb44 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c0faf2b-21fb-4830-bb78-5f2dbceb2c82 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c3199508-3d6a-4e44-96f0-bbde9969edcb (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 to 16 hours.
12 hours
- Numeric value
- 12
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e738dbd9-f4cc-49a0-98ce-73dd0c3ff3b3 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The T max of fingolimod is 12 hours to 16 hours.
Projected row 618
- Medicine slug
- fingolimod
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 21
- Source count
- 21
- Agreement rate
- 0.714286
- Recorded readings
1200 ± 260 L
- Numeric value
- 1,200
- Unit
- L
- Source records
- 15
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 15 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1171df44-48b4-6ef2-e063-6294a90aa121 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200 ± 260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5434bd4a-2610-0e17-4f14-513ff1cbb822 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200 ± 260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5402dd1-c496-405d-9cae-07ccf184339c (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200 ± 260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6301307-55c6-4b91-a505-ff93c865f859 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200 ± 260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc9e1c8c-0e2b-44e2-878b-27057f786be9 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200 ± 260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b228dac8-b07d-424d-b23b-a03573517c54 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200±260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56badc2a-6747-9284-300e-bf072eb072ed (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200±260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9aa1078-fd72-47ef-84b2-2e1ad17b12a2 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200 ± 260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54bf842e-9772-424d-87b2-61863b6f4b19 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200 ± 260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65e59a51-c9c2-47b4-84fc-e0f8879eb26c (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200±260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8fe14efd-8f61-40db-9069-bb17daf3261a (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200±260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99e7daf4-ea90-5e47-e053-2a95a90ac1b7 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200 ± 260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:550a5fa3-94a4-0b55-9cb5-c0178acfe319 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200 ± 260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0538769-3cec-4cf2-97e5-41e79599c181 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200 ± 260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c3199508-3d6a-4e44-96f0-bbde9969edcb (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1200 ± 260 L.
1,200 ± 260 L
- Numeric value
- 1,200
- Unit
- L
- Source records
- 6
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 6 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd981e18-1766-4a2d-9a9b-965ec960aa06 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1,200 ± 260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e738dbd9-f4cc-49a0-98ce-73dd0c3ff3b3 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1,200±260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a545c6fc-7006-52c2-f476-34e9801ac04f (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1,200 ± 260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1960f9b-f739-452c-b167-245551bf3690 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1,200±260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f638feb-6986-41e4-8f9c-2e6b84a5bb44 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1,200±260 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c0faf2b-21fb-4830-bb78-5f2dbceb2c82 (opens source in a new tab)
Fingolimod label
Version not recorded · Effective date not recorded
Fingolimod is extensively distributed to body tissues with a volume of distribution of about 1,200 ± 260 L.
Projected row 619
- Medicine slug
- flecainide
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 35
- Source count
- 35
- Agreement rate
- 1
- Recorded readings
20 hours
- Numeric value
- 20
- Unit
- hours
- Source records
- 35
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 35 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a900f29-85e1-464c-ae9e-44dc7cf11f46 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74c1eb2a-a37f-4f33-86bf-51e0d1d0c2bc (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b73e32f-851b-4503-8296-e5db3a584b75 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0416c8c-faae-4e31-aa50-1fb7df10abf0 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bc304b04-9373-4e47-905d-6b3367ad3be7 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a2a5e08-2697-4a00-94fe-de07148acbd9 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:166aa9e4-3402-4ebd-baa5-07a8da8aae56 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f53e1a49-6185-6db4-c867-ffd1241a8cb7 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5d6a4772-663e-468d-a8e1-4085e1b32bf7 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5a12889a-52ce-4dc4-9240-22d126f071ac (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf143926-439b-4005-be0e-1e049b44c044 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b33e96a-8336-46c4-aac7-4a6c0039cc80 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9929c166-8ba3-4159-a5f9-4618d5d227b0 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b821ec16-93ff-4569-9fbb-4f3842c58bec (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a30103c5-a261-49a5-a7b3-f43eb77e87b7 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d462d58e-fc3c-4c92-a210-e135eb1f4b77 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f6b78d4-8ac8-464b-bb78-ee70cbc97898 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d34fae51-3658-4456-b3ea-1217f0f52260 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45d39dff-22d9-4c04-af26-0cffd41abaa8 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b336028-1e13-4ef7-b75e-345bc9c06f9a (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee590951-cce8-4a1e-b3bd-ae0b610ebda9 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74355cd2-b50e-0dc2-e053-2a91aa0aa164 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee9595d5-08a1-4529-9215-ddc3c7f929c4 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14e89448-3a18-42e3-8537-2589be1ef94e (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a604aee4-30d5-4007-9882-98137d0d867f (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abcb261b-30ae-4eb1-baf0-e9667a2bd8cf (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8dc86db1-2a09-4625-80eb-ff6ce9de2d7a (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e56335c1-5508-4136-bd2e-18385623e497 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:179e3821-0342-4b84-96bb-3fcab213d74f (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5dc5b522-f16f-4b3b-b325-f4ace495f966 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5cfa10ba-dfe8-42ab-81b3-8cca657aba07 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2013e6ef-9141-42c3-8ea8-285840ecdd15 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:475a52a9-f18c-4a69-91f0-8f5e601f4336 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf810a3b-1a71-4a05-bf54-d5a6caba444b (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2028149f-6fc0-455c-bac5-729eeaa4aee5 (opens source in a new tab)
Flecainide label
Version not recorded · Effective date not recorded
The apparent plasma half-life averages about 20 hours and is quite variable (range, 12 to 27 hours) after multiple oral doses in patients with premature ventricular contractions (PVCs).
Projected row 620
- Medicine slug
- fluconazole
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 102
- Source count
- 102
- Agreement rate
- 1
- Recorded readings
90%
- Numeric value
- 90
- Unit
- %
- Source records
- 102
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 102 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2c7242d-d172-4733-e053-2995a90acb2e (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db886cfe-ea23-50c9-e053-2995a90a4d10 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3208dc64-6117-4b2d-9008-76a819cef7d7 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:08a54805-4fdf-48fd-bc3e-e9fa38f3c691 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:afde17e7-b95b-4cd5-97eb-e361724014bd (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd7ea788-29b7-1f0b-e053-6394a90a2980 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:28d53f27-a0cd-4d8d-e054-00144ff8d46c (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:124c1ffa-08fd-eca5-e063-6294a90af0e2 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a3ba181-5baa-5942-e063-6294a90a82b2 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0f1c111-e11e-4b7e-b990-8bc271cbc940 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f25f31a6-4bad-40fa-bced-695552e27afd (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5cbd78cd-2cd7-4882-9902-bdb7812fbc6b (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eeeb82e1-d668-418e-9716-f8bcf72f80c0 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e222031d-58f6-46d6-99f8-320b9aacf2b2 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2099c3a0-1911-4d4a-878a-36cf054bdd0b (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:726daf35-4c03-464f-a814-cc0a715d6031 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90538767-c84b-4637-8ab6-8c147315eafa (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6ebf24fd-41cd-4b3c-8176-a1436253ba2d (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa2fa2f8-f3a6-4bc0-943c-03dabd0f1581 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fbb1bda3-f733-4404-9c9d-46c418700c03 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0adb2f88-8a6f-4f33-9e2d-73f537e05313 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b9b08b6-7239-473b-e063-6294a90ab7c4 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01df20c4-7b94-044e-e063-6394a90a406a (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13184b13-e252-4b4d-a3e2-cfc4ad3d55b7 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4616c7ad-be61-7ac0-e063-6394a90ab9ed (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cbf3c6c-318c-4dd9-ad44-a8eb9eccb0f5 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc4fccd8-19d2-4704-afa9-9ce0ab1d2b5f (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7fa1d79-4cd3-4a55-b74b-b31e82e616a3 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:701cd91f-4f79-48a7-8fe5-a9678d7a4ac8 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:83bcb8fc-53f1-4d7b-b083-0905b52c6c7e (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8aa296e2-ad8d-42f6-8b41-468e2b9cdfb8 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7961c029-746c-48c3-888b-8f8344102873 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f76bf2f7-1752-7656-e053-6394a90a8d22 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf6c7cca-d074-2178-e053-2a95a90a3af7 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0aacafca-baf8-9a22-e063-6394a90a2ca9 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f743514-615e-4e78-8321-24c545a7752f (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f232600e-70ce-4001-b9da-31442f0920b9 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7c8bb5ff-37e7-4f5e-8ea7-12269b2c7fd3 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe0cc56d-c0b6-f859-e053-6294a90ad932 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b94ca865-ab2f-466c-9913-dde9376e4533 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:877aea10-b019-4eeb-8a1e-e6ac583df966 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c041227b-dab6-4c29-ab59-d31993d524b2 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:02f74fe7-0649-46c5-a06a-0700cd265773 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fef2222c-5d61-435e-8761-d8f3d435d6d8 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3da5f41d-5200-45ac-b89d-00881237ec85 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a4d6d9e-02ae-42e4-83ec-f5c4e135273b (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67af604c-928f-468b-ba27-ad45e95d3e7e (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16b6fba0-b96f-4252-a70d-31dc61400298 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f86ea347-78f5-43b8-9574-a52569a4237b (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:737e0fac-a2d2-4053-a0d7-edbfb6248f69 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56a9de97-bbb9-4210-9ace-f77317d5f33b (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2fcac0e4-4f12-42d2-b129-106b4e100075 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf588f7e-89de-4b4e-8d33-c1ff2be1b34e (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b2bc10f-21a8-422a-9ea3-ed7788ffce6b (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c82929f-934b-4df4-b24f-1e5da090fd8a (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6be26bb-af92-405b-9908-972d6e985cf0 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7259671f-a703-4a2a-81db-9a4839b34072 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f694c617-3383-416c-91b6-b94fda371204 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:519e44f4-9318-572e-e063-6394a90afe93 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd975843-c3e4-44f4-bb0d-33b294c1f6fb (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c89c3bbd-1170-4170-e053-2a95a90a8e41 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c0193e27-f1a4-4698-a6bb-3df772c16256 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d2acccda-8068-46c1-8562-950d7f70ee06 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ca7efcd-4a8d-4139-a3eb-930afd18b13f (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c94b8ecf-249f-42d6-a030-4cfb83fddb08 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:177322f4-9526-40cb-9e5d-bc24e8fb02db (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06f8f4b9-5289-2d59-e063-6294a90a7209 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a8bd42a-2bce-4b41-8678-67033e7707dd (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:98ac5455-d26c-4780-a5a3-bf8d85917626 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60f3e8af-d98f-48dd-83e6-a78315aaed22 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1364455-1537-46d4-b093-38cca3be778f (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91adb548-9875-47e9-8054-578ed8c7572e (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a995790a-8470-4c51-801a-69347151a6fe (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0de7211d-b8ce-214d-e063-6294a90aec41 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6bb386b0-9dbe-40ee-b873-5215b1905920 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f90f169-6a72-4c33-a2af-0bc943602bc2 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:325d5d69-5132-79ea-e063-6294a90afdd0 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a499c43e-0454-4a8c-a547-31e9816babdd (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22ebc3fb-ee81-44bd-a6e3-5e759ee724a8 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:068623f9-0f87-50bc-e063-6294a90aea00 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13804efd-7cb3-431f-a6a7-bd6d1da5889e (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9e772e9-d916-42ae-8020-89b263236102 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aaf9e5f8-048e-407c-bc11-ad4edff85c05 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c9abaee-461f-437d-adda-e96d7ae3dd01 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:126406ae-1fdc-df20-e063-6294a90a2718 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:485f0414-036f-4f42-87ee-a89543ac94c1 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:69f199fa-bb92-4837-8b12-427a1c71f622 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4eaf5b04-c026-4a49-879f-2925b375f903 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bd1c038-ab82-496c-8129-3182238ad1a1 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:551a5c8f-57eb-2643-12c6-7c700584b49f (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c924c51c-ed7e-7e72-e053-2995a90adcd3 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1bfba3a-5b18-41c0-9084-b1f26bb93ef2 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3ca59bd-ae00-48ab-89aa-87c7f56e9989 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ccbe0991-27a1-4ddb-bfc7-1b3422e53390 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b0aa9b22-5aef-459f-bb11-b193343eeb86 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88d9904c-0c21-4188-95e2-6479bdf359df (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:715c53f0-2aea-1f24-e053-2995a90ad463 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7aacee3-9d9c-4b36-b735-39bcb9edf941 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b3db505a-9677-6f5a-e053-2a95a90a13d4 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cd24a261-9c15-42b4-8040-89d2dbda174e (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:568d9f2f-3394-b972-e063-6394a90a8628 (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b5cfe0a1-f55c-41b1-8ad6-d1d0134a4d1d (opens source in a new tab)
Fluconazole label
Version not recorded · Effective date not recorded
In normal volunteers, the bioavailability of orally administered fluconazole is over 90% compared with intravenous administration.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=610Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.